Peptide record

TPDB08637

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08637
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 17-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
AAPRGGKGFFCKLFKDC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C84H129N23O20S2
NEQHIMSTWYV
GKF
1845.21
9.80
4
1
6
+3
1.03
-0.100
34.71
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
125
0.07
2
Residue Composition
number
2
A
1
R
0
N
1
D
2
C
0
E
0
Q
3
G
0
H
0
I
1
L
3
K
0
M
3
F
1
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 1 C: 2 E: 0 Q: 0 G: 3 H: 0 I: 0 L: 1 K: 3 M: 0 F: 3 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
17 reviewed residue count
C84H129N23O20S2 sequence-only estimate (linear, free termini)
1845.21 sequence-only estimate (linear, free termini)
9.80 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
1.03 sequence-only estimate (linear, free termini)
-0.100 sequence-only estimate (linear, free termini)
Evidence Records 10 records
Evidence 1 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
weakly active against B. pyocyaneus (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

kly active against B. pyocyaneus (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

us (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 4 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
weakly active against B. pyocyaneus (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 5 Activity

Activity

MIC
Antifungal
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

kly active against B. pyocyaneus (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

us (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 7 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
weakly active against B. pyocyaneus (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 8 Activity

Activity

MIC
Antiparasitic
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

kly active against B. pyocyaneus (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 9 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

us (p. aeruginosa) (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), and C. albicans (MIC 100 ug/ml).
Evidence 10 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. | J Proteome Res | 2012